MapLight Therapeutics, Inc. (MPLT) Misses Q1 EPS by 42c
Tweet
Share
E-mailGet Alerts MPLT Hot Sheet
Join SI Premium – FREE
MapLight Therapeutics, Inc. (NASDAQ: MPLT) reported Q1 EPS of ($1.34), $0.42 worse than the analyst estimate of ($0.92).
For earnings history and earnings-related data on MapLight Therapeutics, Inc. (MPLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Ocean Power Technologies revises fiscal 2026 results after audit
- TJX stock drops as profit outlook falls short of analyst estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
